2017 Business Transactions at a Glance

In 2017, Smith Anderson advised clients in more than 300 transactions representing more than $11 billion in value, including mergers, acquisitions and public offerings; debt finance, private equity and mezzanine finance; real estate development and construction; life sciences, health care, technology and intellectual property; venture capital and angel financings.

The following provides a comprehensive overview of some of our clients' key business transactions in 2017. Highlights include: 

• Over 40 mergers, acquisitions and public offerings totaling more than $2 billion in value, in addition to serving as North Carolina counsel to British American Tobacco p.l.c. on its $50 billion merger with Reynolds American Inc. 
• Over 100 debt finance, private equity and mezzanine finance transactions totaling more than $3.5 billion in value, including representing New Hanover Regional Medical Center in its $240 million offering of tax-exempt hospital revenue bonds.
• Over 100 real estate and construction matters totaling more than $2 billion, including representing GlaxoSmithKline LLC in the sale and partial leaseback of its RTP campus.
• Over 65 life sciences, IP, health care and technology transactions totaling more than $2.7 billion in value, including assisting in license spinouts of technology from various universities including: Harvard, MIT, the University of California system, Duke, North Carolina State and University of North Carolina. 
• Over 85 venture capital and angel financings totaling more than $565 million in value.
• Overall, over 300 deals representing more than $11 billion in value.

VIEW OUR 2017 BUSINESS TRANSACTIONS